Additionally, it has been shown that ASCT2 (alanine-serine-cysteine transporter 2), an essential glutamine transporter, is upregulated by mutant KRAS, and its knockout reduces cell proliferation and migration in CRC. This evidence concerns the gene KRAS and colorectal carcinoma.